With the goal of obtaining sufficient functional protein for structura
l analysis, rat neurokinin-2 receptor was produced in Escherichia coli
by linking it to the periplasmic maltose-binding protein. As a first
step, we present a biochemical and pharmacological investigation of th
e recombinant receptor. Western-blots showed that the fusion protein w
as associated with the membranes. The agonist [4,5-H-3-Leu(9)]neurokin
in A and the NK-2 antagonist [H-3]SR48,968 bound to the receptor in a
highly specific manner. Saturation binding of the [3H]agonist demonstr
ated a single class of receptors (K-D = 10.5 nM, B-max = 2.5 pmol/mg p
rotein). The [H-3]antag- onist bound with higher affinity to a larger
receptor population (K-D = 0.2 nM, B-max = 7.2 pmol/mg protein). Compe
tition of [H-3]agonist binding with other agonists demonstrated a pote
ncy order of: neurokinin A > [Nle(10)]NKA(4-10) = [beta-Ala(8)]NKA(4-1
0) >> substance P >>> senktide. Against the [H-3]antagonist, agonists
were only partially inhibitory. Selective NK-2 antagonists inhibited b
inding of both [3H]ligands with an identical order of potency: SR48,96
8 >> R396 > MEN10,376, which is consistent with NK-2 receptor pharmaco
logy in rat tissue.